Factorial analysis extracted 4 significant factors (Dyslipidemia-redox balance inflammation related factor (TOS, TAS, PAB, PCSK9 and CRP), Coronary risk intervention-related factor (Total CK activity, ALT, AST and octacosanol supplement status – yes/no), Lipid risk-protein related redox factor (AOPP, SHG and ApoB100) and Metabolic-related antioxidant factor (ApoA1, Glucose and PON1)) which explained 55.0% of the total variance. The gene discussed is APOB; the disease is metabolic syndrome.